Olga Hartwig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Olga Hartwig has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Brigitta Loretz
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany
2 shared publications - Claus-Michael Lehr
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany
2 shared publications - Alexandra K. Kiemer
Department of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrücken, Germany
1 shared publication - Alf Lamprecht
Department of Pharmaceutics, Institute of Pharmacy, University of Bonn, Bonn, Germany
1 shared publication Aline Van Acker
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
1 shared publicationAnastasios Damdimopoulos
Bioinformatics and Expression Analysis Core Facility, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
1 shared publication
Latest Publications
- Open Access
- 26 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF
Stromal cells support epithelial cell and immune cell homeostasis and play an important role in inflammatory bowel disease (IBD) pathogenesis. Here, we quantify the stromal response to inflammation in pediatric IBD and reveal subset-specific inflammatory responses across colon segments and intestinal layers. Using data from a murine dynamic gut injury model and human ex vivo transcriptomic, protein and spatial analyses, we report that PDGFRA+CD142−/low fibroblasts and monocytes/macrophages co-localize in the intestine. In primary human fibroblast-monocyte co-cultures, intestinal PDGFRA+CD142−/low fibroblasts foster monocyte transition to CCR2+CD206+ macrophages through granulocyte-macrophage colony-stimulating factor (GM-CSF). Monocyte-derived CCR2+CD206+ cells from co-cultures have a phenotype similar to intestinal CCR2+CD206+ macrophages from newly diagnosed pediatric IBD patients, with high levels of PD-L1 and low levels of GM-CSF receptor. The study describes subset-specific changes in stromal responses to inflammation and suggests that the intestinal stroma guides intestinal macrophage differentiation.
- 26 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessIntestinal stroma guides monocyte differentiation to macrophages through GM-CSF
Stromal cells support epithelial cell and immune cell homeostasis and play an important role in inflammatory bowel disease (IBD) pathogenesis. Here, we quantify the stromal response to inflammation in pediatric IBD and reveal subset-specific inflammatory responses across colon segments and intestinal layers. Using data from a murine dynamic gut injury model and human ex vivo transcriptomic, protein and spatial analyses, we report that PDGFRA+CD142−/low fibroblasts and monocytes/macrophages co-localize in the intestine. In primary human fibroblast-monocyte co-cultures, intestinal PDGFRA+CD142−/low fibroblasts foster monocyte transition to CCR2+CD206+ macrophages through granulocyte-macrophage colony-stimulating factor (GM-CSF). Monocyte-derived CCR2+CD206+ cells from co-cultures have a phenotype similar to intestinal CCR2+CD206+ macrophages from newly diagnosed pediatric IBD patients, with high levels of PD-L1 and low levels of GM-CSF receptor. The study describes subset-specific changes in stromal responses to inflammation and suggests that the intestinal stroma guides intestinal macrophage differentiation.
- Open Access
Cell‐Derived Vesicles for Antibiotic Delivery—Understanding the Challenges of a Biogenic Carrier System
Recently, extracellular vesicles (EVs) sparked substantial therapeutic interest, particularly due to their ability to mediate targeted transport between tissues and cells. Yet, EVs’ technological translation as therapeutics strongly depends on better biocompatibility assessments in more complex models and elementary in vitro–in vivo correlation, and comparison of mammalian versus bacterial vesicles. With this in mind, two new types of EVs derived from human B‐lymphoid cells with low immunogenicity and from non‐pathogenic myxobacteria SBSr073 are introduced here. A large‐scale isolation protocol to reduce plastic waste and cultivation space toward sustainable EV research is established. The biocompatibility of mammalian and bacterial EVs is comprehensively evaluated using cytokine release and endotoxin assays in vitro, and an in vivo zebrafish larvae model is applied. A complex three‐dimensional human cell culture model is used to understand the spatial distribution of vesicles in epithelial and immune cells and again used zebrafish larvae to study the biodistribution in vivo. Finally, vesicles are successfully loaded with the fluoroquinolone ciprofloxacin (CPX) and showed lower toxicity in zebrafish larvae than free CPX. The loaded vesicles are then tested effectively on enteropathogenic Shigella, whose infections are currently showing increasing resistance against available antibiotics.
Open AccessCell‐Derived Vesicles for Antibiotic Delivery—Understanding the Challenges of a Biogenic Carrier System
Recently, extracellular vesicles (EVs) sparked substantial therapeutic interest, particularly due to their ability to mediate targeted transport between tissues and cells. Yet, EVs’ technological translation as therapeutics strongly depends on better biocompatibility assessments in more complex models and elementary in vitro–in vivo correlation, and comparison of mammalian versus bacterial vesicles. With this in mind, two new types of EVs derived from human B‐lymphoid cells with low immunogenicity and from non‐pathogenic myxobacteria SBSr073 are introduced here. A large‐scale isolation protocol to reduce plastic waste and cultivation space toward sustainable EV research is established. The biocompatibility of mammalian and bacterial EVs is comprehensively evaluated using cytokine release and endotoxin assays in vitro, and an in vivo zebrafish larvae model is applied. A complex three‐dimensional human cell culture model is used to understand the spatial distribution of vesicles in epithelial and immune cells and again used zebrafish larvae to study the biodistribution in vivo. Finally, vesicles are successfully loaded with the fluoroquinolone ciprofloxacin (CPX) and showed lower toxicity in zebrafish larvae than free CPX. The loaded vesicles are then tested effectively on enteropathogenic Shigella, whose infections are currently showing increasing resistance against available antibiotics.
- 19 December 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 353, 915-929
Proteoid biodynamers for safe mRNA transfection via pH-responsive nanorods enabling endosomal escape
- 19 December 2022
- Published by Elsevier in Journal of Controlled Release
- Vol. 353, 915-929
Proteoid biodynamers for safe mRNA transfection via pH-responsive nanorods enabling endosomal escape
- Open Access
- 5 January 2022
- Published by Springer Nature in Hereditas
- Vol. 159 (1) , 1-23
Regulatory modules mediating the complex neural expression patterns of the homeobrain gene during Drosophila brain development
Background: The homeobox genehomeobrain(hbn) is located in the 57B region together with two other homeobox genes,Drosophila Retinal homeobox(DRx) andorthopedia(otp). All three genes encode transcription factors with important functions in brain development.Hbnmutants are embryonic lethal and characterized by a reduction in the anterior protocerebrum, including the mushroom bodies, and a loss of the supraoesophageal brain commissure.Results: In this study we conducted a detailed expression analysis of Hbn in later developmental stages. In the larval brain, Hbn is expressed in all type II lineages and the optic lobes, including the medulla and lobula plug. The gene is expressed in the cortex of the medulla and the lobula rim in the adult brain. We generated a new hbnKOGal4enhancer trap strain by reintegrating Gal4 in thehbnlocus through gene targeting, which reflects the completehbnexpression during development. Eight different enhancer-Gal4 strains covering 12 kb upstream ofhbn, the two large introns and 5 kb downstream of the gene, were established andhbnexpression was investigated. We characterized several enhancers that drive expression in specific areas of the brain throughout development, from embryo to the adulthood. Finally, we generated deletions of four of these enhancer regions through gene targeting and analysed their effects on the expression and function ofhbn.Conclusion: The complex expression of Hbn in the developing brain is regulated by several specific enhancers within thehbnlocus. Each enhancer fragment driveshbnexpression in several specific cell lineages, and with largely overlapping patterns, suggesting the presence of shadow enhancers and enhancer redundancy. Specific enhancer deletion strains generated by gene targeting display developmental defects in the brain. This analysis opens an avenue for a deeper analysis ofhbnregulatory elements in the future.
- 5 January 2022
- Published by Springer Nature in Hereditas
- Vol. 159 (1) , 1-23
Open AccessRegulatory modules mediating the complex neural expression patterns of the homeobrain gene during Drosophila brain development
Background: The homeobox genehomeobrain(hbn) is located in the 57B region together with two other homeobox genes,Drosophila Retinal homeobox(DRx) andorthopedia(otp). All three genes encode transcription factors with important functions in brain development.Hbnmutants are embryonic lethal and characterized by a reduction in the anterior protocerebrum, including the mushroom bodies, and a loss of the supraoesophageal brain commissure.Results: In this study we conducted a detailed expression analysis of Hbn in later developmental stages. In the larval brain, Hbn is expressed in all type II lineages and the optic lobes, including the medulla and lobula plug. The gene is expressed in the cortex of the medulla and the lobula rim in the adult brain. We generated a new hbnKOGal4enhancer trap strain by reintegrating Gal4 in thehbnlocus through gene targeting, which reflects the completehbnexpression during development. Eight different enhancer-Gal4 strains covering 12 kb upstream ofhbn, the two large introns and 5 kb downstream of the gene, were established andhbnexpression was investigated. We characterized several enhancers that drive expression in specific areas of the brain throughout development, from embryo to the adulthood. Finally, we generated deletions of four of these enhancer regions through gene targeting and analysed their effects on the expression and function ofhbn.Conclusion: The complex expression of Hbn in the developing brain is regulated by several specific enhancers within thehbnlocus. Each enhancer fragment driveshbnexpression in several specific cell lineages, and with largely overlapping patterns, suggesting the presence of shadow enhancers and enhancer redundancy. Specific enhancer deletion strains generated by gene targeting display developmental defects in the brain. This analysis opens an avenue for a deeper analysis ofhbnregulatory elements in the future.
- 1 August 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 175, 113828
Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD
- 1 August 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 175, 113828
Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD